Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB CAMSYLATE for Illness: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where RUCAPARIB CAMSYLATE was used for Illness.

Most Reported Side Effects for RUCAPARIB CAMSYLATE

Side Effect Reports % Deaths Hosp.
Fatigue 2,494 30.3% 40 335
Nausea 2,219 26.9% 40 333
Malignant neoplasm progression 1,162 14.1% 69 139
Decreased appetite 787 9.6% 17 148
Constipation 763 9.3% 12 123
Diarrhoea 759 9.2% 19 109
Vomiting 759 9.2% 24 184
Asthenia 660 8.0% 24 148
Adverse event 571 6.9% 22 269
Carbohydrate antigen 125 increased 562 6.8% 10 85
Dysgeusia 558 6.8% 8 86
Product dose omission issue 542 6.6% 2 42
Platelet count decreased 527 6.4% 6 100
Anaemia 496 6.0% 14 114
Drug ineffective 490 6.0% 13 41

Other Indications for RUCAPARIB CAMSYLATE

Ovarian cancer (6,318) Product used for unknown indication (462) Prostate cancer (391) Fallopian tube cancer (385) Malignant peritoneal neoplasm (332) Ovarian cancer recurrent (101) Neoplasm malignant (56) Pancreatic carcinoma (55) Gene mutation (52) Endometrial cancer (49)

Other Drugs Used for Illness

DUPILUMAB (4,122) MEPOLIZUMAB (372) CERTOLIZUMAB PEGOL (283) ABALOPARATIDE (179) LENALIDOMIDE (164) TERIFLUNOMIDE (153) SARILUMAB (130) CABOTEGRAVIR (117) AZTREONAM LYSINE (92) RISANKIZUMAB-RZAA (79)

Related Pages

RUCAPARIB CAMSYLATE Full Profile All Illness Drugs RUCAPARIB CAMSYLATE Demographics RUCAPARIB CAMSYLATE Timeline